Trial · NCT00748098
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| First Treatment Intervention Period | STARTED | Placebo Followed by GEn 1200 mg/Day | 69 | |
| First Treatment Intervention Period | STARTED | GEn 1200 mg/Day Followed by Placebo | 67 | |
| First Treatment Intervention Period | COMPLETED | Placebo Followed by GEn 1200 mg/Day | 64 | |
| First Treatment Intervention Period | COMPLETED | GEn 1200 mg/Day Followed by Placebo | 66 | |
| First Treatment Intervention Period | NOT COMPLETED | Placebo Followed by GEn 1200 mg/Day | 5 | |
| First Treatment Intervention Period | NOT COMPLETED | GEn 1200 mg/Day Followed by Placebo | 1 | |
| First Taper Period | STARTED | Placebo Followed by GEn 1200 mg/Day | 64 | |
| First Taper Period | STARTED | GEn 1200 mg/Day Followed by Placebo | 66 | |
| First Taper Period | COMPLETED | Placebo Followed by GEn 1200 mg/Day | 61 | |
| First Taper Period | COMPLETED | GEn 1200 mg/Day Followed by Placebo | 65 | |
| First Taper Period | NOT COMPLETED | Placebo Followed by GEn 1200 mg/Day | 3 | |
| First Taper Period | NOT COMPLETED | GEn 1200 mg/Day Followed by Placebo | 1 | |
| 1-Week Washout Period | STARTED | Placebo Followed by GEn 1200 mg/Day | 61 | |
| 1-Week Washout Period | STARTED | GEn 1200 mg/Day Followed by Placebo | 65 | |
| 1-Week Washout Period | COMPLETED | Placebo Followed by GEn 1200 mg/Day | 59 | |
| 1-Week Washout Period | COMPLETED | GEn 1200 mg/Day Followed by Placebo | 64 | |
| 1-Week Washout Period | NOT COMPLETED | Placebo Followed by GEn 1200 mg/Day | 2 | |
| 1-Week Washout Period | NOT COMPLETED | GEn 1200 mg/Day Followed by Placebo | 1 | |
| Second Treatment Intervention Period | STARTED | Placebo Followed by GEn 1200 mg/Day | 59 | |
| Second Treatment Intervention Period | STARTED | GEn 1200 mg/Day Followed by Placebo | 64 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00748098/flow